SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 203 filers reported holding SAGE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $467 | -55.5% | 22,688 | +1.7% | 0.00% | 0.0% |
| Q2 2023 | $1,049 | -11.2% | 22,309 | -20.8% | 0.00% | -50.0% |
| Q1 2023 | $1,181 | -20.7% | 28,151 | -27.9% | 0.00% | 0.0% |
| Q4 2022 | $1,490 | -99.9% | 39,058 | +0.0% | 0.00% | 0.0% |
| Q3 2022 | $1,529,000 | +29.7% | 39,051 | +7.0% | 0.00% | 0.0% |
| Q2 2022 | $1,179,000 | -51.2% | 36,508 | -50.0% | 0.00% | -33.3% |
| Q1 2022 | $2,415,000 | -17.8% | 72,946 | +5.7% | 0.00% | 0.0% |
| Q4 2021 | $2,937,000 | -7.1% | 69,033 | -3.2% | 0.00% | 0.0% |
| Q3 2021 | $3,161,000 | -54.4% | 71,347 | -41.5% | 0.00% | -57.1% |
| Q2 2021 | $6,929,000 | -26.5% | 121,965 | -3.2% | 0.01% | -30.0% |
| Q1 2021 | $9,426,000 | -20.7% | 125,936 | -8.3% | 0.01% | -23.1% |
| Q4 2020 | $11,881,000 | +49.9% | 137,336 | +5.9% | 0.01% | +30.0% |
| Q3 2020 | $7,925,000 | +60.8% | 129,669 | +9.4% | 0.01% | +66.7% |
| Q2 2020 | $4,928,000 | -11.0% | 118,526 | -38.5% | 0.01% | -25.0% |
| Q1 2020 | $5,539,000 | -64.3% | 192,879 | -10.4% | 0.01% | -55.6% |
| Q4 2019 | $15,536,000 | -58.6% | 215,212 | -19.6% | 0.02% | -62.5% |
| Q3 2019 | $37,560,000 | -24.8% | 267,731 | -1.9% | 0.05% | -23.8% |
| Q2 2019 | $49,953,000 | +11.4% | 272,833 | -3.2% | 0.06% | +8.6% |
| Q1 2019 | $44,838,000 | +71.2% | 281,913 | +3.1% | 0.06% | +52.6% |
| Q4 2018 | $26,190,000 | -30.5% | 273,407 | +2.5% | 0.04% | -15.6% |
| Q3 2018 | $37,695,000 | -10.3% | 266,868 | -0.6% | 0.04% | -13.5% |
| Q2 2018 | $42,039,000 | +49.4% | 268,568 | +53.8% | 0.05% | +48.6% |
| Q1 2018 | $28,131,000 | +6.5% | 174,650 | +9.0% | 0.04% | +9.4% |
| Q4 2017 | $26,402,000 | +183.3% | 160,295 | +7.2% | 0.03% | +166.7% |
| Q3 2017 | $9,318,000 | +180.0% | 149,564 | +258.0% | 0.01% | +200.0% |
| Q2 2017 | $3,328,000 | +22.3% | 41,782 | +9.1% | 0.00% | 0.0% |
| Q1 2017 | $2,721,000 | +30.0% | 38,283 | -6.6% | 0.00% | +33.3% |
| Q4 2016 | $2,093,000 | +42.6% | 40,988 | +28.5% | 0.00% | +50.0% |
| Q3 2016 | $1,468,000 | +195.4% | 31,888 | +93.3% | 0.00% | +100.0% |
| Q2 2016 | $497,000 | -23.5% | 16,500 | -18.6% | 0.00% | 0.0% |
| Q1 2016 | $650,000 | -36.3% | 20,263 | +15.8% | 0.00% | -50.0% |
| Q4 2015 | $1,020,000 | +37.7% | 17,501 | 0.0% | 0.00% | +100.0% |
| Q3 2015 | $741,000 | -30.4% | 17,501 | +20.1% | 0.00% | -50.0% |
| Q2 2015 | $1,064,000 | +511.5% | 14,577 | +321.1% | 0.00% | – |
| Q1 2015 | $174,000 | – | 3,462 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |